Mustang Bio (MBIO) Other Accumulated Expenses (2022 - 2026)

Mustang Bio (MBIO) has reported Other Accumulated Expenses for 5 consecutive years, with $2.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Accumulated Expenses fell 10.38% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $2.5 million (down 10.38% YoY), while the FY2025 annual figure was $2.5 million, down 6.15% from the prior year.
• Other Accumulated Expenses grew to $2.5 million in Q1 2026 per MBIO's latest filing, from $2.5 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $2.8 million in Q1 2025 and bottomed at $766000.0 in Q4 2022.
• Historically, Other Accumulated Expenses has averaged $2.0 million across 5 years, with a median of $2.5 million in 2025.
• Annual changes were most pronounced in 2024 — Other Accumulated Expenses surged 219.78% — and 2026, when it declined 10.38%.
• Mustang Bio's Other Accumulated Expenses stood at $766000.0 in 2022, then grew by 8.88% to $834000.0 in 2023, then soared by 219.78% to $2.7 million in 2024, then dropped by 6.15% to $2.5 million in 2025, then increased by 0.72% to $2.5 million in 2026.
• Business Quant data shows MBIO's Other Accumulated Expenses at $2.5 million in Q1 2026, $2.5 million in Q4 2025, and $2.5 million in Q3 2025.